High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors
Chinese Clinical Oncology · 2021-06 · 10 (3) · 26-26
DOI: 10.21037/cco-20-226 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Chinese Clinical Oncology, 2021-06. Verfasst von Laura Bender und 9 weiteren Autor:innen. Beteiligte Einrichtung: Radiotherapy Department, Institut de Cancérologie Strasbourg-Europe, Strasbourg, France. Hauptthemen laut MEDLINE: Meningeal Neoplasms, Meningioma, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 17-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Radiotherapy Department, Institut de Cancérologie Strasbourg-Europe, Strasbourg, France.
- Nuclear Medicine Department, Institut de Cancérologie Strasbourg-Europe, Strasbourg, France.
- Pathology Department, Hôpital de Hautepierre, 1 avenue Molière, Strasbourg, France.
- Neurology Department, Hôpitaux Civils, Colmar, France.
- Neurology Department, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France.
- Neurology Department, CHRU Nancy, Nancy, France; .
Zitieren
APA
Bender, L., Somme, F., Lhermitte, B., Ahle, G., Boone, M., Blonski, M., Pouget, C., Truc, G., Cebula, H., & Noël, G. (2021). High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors. Chinese Clinical Oncology, 10(3), 26-26. https://doi.org/10.21037/cco-20-226
Vancouver
Bender L, Somme F, Lhermitte B, Ahle G, Boone M, Blonski M, et al. High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors. Chinese Clinical Oncology. 2021;10(3):26-26. doi:10.21037/cco-20-226
BibTeX
@article{Bender2021,
author = {Bender, Laura and Somme, François and Lhermitte, Benoît and Ahle, Guido and Boone, Mathieu and Blonski, Marie and Pouget, Celso and Truc, Gilles and Cebula, Hélène and Noël, Georges},
title = {High risk of recurrence for grade II meningioma: a 10-year multicenter analysis of prognosis factors},
journal = {Chinese Clinical Oncology},
year = {2021},
volume = {10},
number = {3},
pages = {26--26},
doi = {10.21037/cco-20-226}
}
EUVIMED